|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 玛伐凯泰>> 市场分析报告 |
玛伐凯泰市场分析报告 |
|
Hypertrophic Cardiomyopathy - Pipeline Review, H1 2020 Hypertrophic Cardiomyopathy - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H1 2020, provides an overview of the Hypertrophic ... Hypertrophic cardiomyopathy - Pipeline Insight, 2021 ... Hypertrophic cardiomyopathy Emerging Drugs Mavacamten: MyoKardia Mavacamten is a first-in-class, oral ... Drug Application (NDA) for mavacamten, a novel therapy for ... company’s clinical program investigating mavacamten in patients with obstructive hypertrophic ... Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Drugs In ... Hypertrophic Cardiomyopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 ... Performance Drugs Company Name Camzyos (Mavacamten) Britol Myers Squibb/MyoKardia CK 3773274 ... Heart failure - Pipeline Insight, 2021 ... TSG-01 Ertugliflozin CDR132L Sildenafil Citrate Mavacamten TT-00920 Sotatercept NAN-101 BIA ... Heart failure with preserved ejection fraction (HFpEF) ... Semaglutide Macitentan AZD4831 Dapagliflozin PL-3994 Mavacamten elamipretide Sildenafil NAN-101 CardiolRx ... Global Hypertrophic Cardiomyopathy HCM Therapeutics Market Research Report 2025(Status and Outlook) ... pathophysiology, such as myosin inhibitors like mavacamten. Additionally, surgical options like septal ... Cardiomyopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major cardiomyopathy markets are expected to exhibit a CAGR of 6.07% during 2024-2034. The cardiomyopathy market has been comprehensively analyzed in IMARC's new report titled "Cardiomyopathy Market: Epidemiology, Industry Trends, Share, Size, Growth ... Germany Generative AI in Chemical Market Assessment, By Model [Deep Learning, Natural Language Processing, Discriminative Model, Reinforcement Learning, Others], By Application [Complex Structure Predictions, Novel Formulation Optimization, Chemical Process Optimization, Real-time Equipment Monitoring, Production Capacity Optimization, Pricing Optimization, Laboratory Automation, Others], By End-user [Chemical Processing Industry, Research & Development, Others], By Region, Opportunities and Forecast, 2016-2030F ... drugs Oteseconazole, Mitapivat, Tapinarof, and Mavacamten. The tool successfully generated the ... United States Generative AI in Chemical Market Assessment, By Model [Deep Learning, Natural Language Processing, Discriminative Model, Reinforcement Learning, Others], By Application [Complex Structure Predictions, Novel Formulation Optimization, Chemical Process Optimization, Real-time Equipment Monitoring, Production Capacity Optimization, Pricing Optimization, Laboratory Automation, Others], By End-user [Chemical Processing Industry, Research & Development, Others], By Region, Opportunities and Forecast, 2016-2030F ... drugs Oteseconazole, Mitapivat, Tapinarof, and Mavacamten. The device successfully generated the ... MyoKardia Inc (MYOK) - Financial and Strategic SWOT Analysis Review ... . Its lead drug product candidate, mavacamten, is intended for the treatment of hypertrophic ... MyoKardia Inc - Strategic SWOT Analysis Review ... . Its lead drug product candidate, mavacamten, is intended for the treatment of hypertrophic ... |